191 related articles for article (PubMed ID: 23453867)
1. The missed opportunities to diagnose and treat iron deficiency in patients hospitalized with heart failure.
Silverberg DS; Schwartz D; Schwartz I; Ben Assa E
Int J Cardiol; 2013 Oct; 168(3):2164-6. PubMed ID: 23453867
[TBL] [Abstract][Full Text] [Related]
2. Dynamic iron status after acute heart failure.
Sportouch L; Cautela J; Resseguier N; Pinto J; Ammar C; Gaubert M; Barraud J; Peyrol M; Laine M; Bonello L; Yvorra S; Paganelli F; Thuny F
Arch Cardiovasc Dis; 2019; 112(6-7):410-419. PubMed ID: 31006624
[TBL] [Abstract][Full Text] [Related]
3. Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure.
Nakano H; Nagai T; Sundaram V; Nakai M; Nishimura K; Honda Y; Honda S; Iwakami N; Sugano Y; Asaumi Y; Aiba T; Noguchi T; Kusano K; Yokoyama H; Ogawa H; Yasuda S; Chikamori T; Anzai T;
Int J Cardiol; 2018 Jun; 261():114-118. PubMed ID: 29580659
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and spectrum of iron deficiency in heart failure patients in south Rajasthan.
Sharma SK; Agarwal SK; Bhargava K; Sharma M; Chopra K; Arumugam G
Indian Heart J; 2016; 68(4):493-7. PubMed ID: 27543471
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
Ponikowski P; Kirwan BA; Anker SD; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Haboubi T; Keren A; Khintibidze I; Kragten H; Martinez FA; McDonagh T; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Jankowska EA
Eur J Heart Fail; 2019 Dec; 21(12):1651-1658. PubMed ID: 31883356
[TBL] [Abstract][Full Text] [Related]
6. Management of iron deficiency and anemia after Roux-en-Y gastric bypass surgery: an observational study.
Malone M; Alger-Mayer S; Lindstrom J; Bailie GR
Surg Obes Relat Dis; 2013; 9(6):969-74. PubMed ID: 23499191
[TBL] [Abstract][Full Text] [Related]
7. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
Schatz U; Illigens BM; Siepmann T; Arneth B; Siegert G; Siegels D; Heigl F; Hettich R; Ramlow W; Prophet H; Bornstein SR; Julius U
Atheroscler Suppl; 2015 May; 18():199-208. PubMed ID: 25936327
[TBL] [Abstract][Full Text] [Related]
8. Criteria for Iron Deficiency in Patients With Heart Failure.
Masini G; Graham FJ; Pellicori P; Cleland JGF; Cuthbert JJ; Kazmi S; Inciardi RM; Clark AL
J Am Coll Cardiol; 2022 Feb; 79(4):341-351. PubMed ID: 35086656
[TBL] [Abstract][Full Text] [Related]
9. Critical re-evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure.
Packer M; Anker SD; Butler J; Cleland JGF; Kalra PR; Mentz RJ; Ponikowski P; Talha KM
Eur J Heart Fail; 2024 Jun; 26(6):1298-1312. PubMed ID: 38727791
[TBL] [Abstract][Full Text] [Related]
10. Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes.
Mistry RH; Kohut A; Ford P
Ann Hematol; 2021 Mar; 100(3):661-666. PubMed ID: 33169197
[TBL] [Abstract][Full Text] [Related]
11. Iron Deficiency, Anemia, and Iron Supplementation in Patients With Heart Failure: A Population-Level Study.
Wahid M; Islam S; Sepehrvand N; Dover DC; McAlister FA; Kaul P; Ezekowitz JA
Circ Heart Fail; 2024 Apr; 17(4):e011351. PubMed ID: 38572652
[TBL] [Abstract][Full Text] [Related]
12. Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial.
Ambrosy AP; Lewis GD; Malhotra R; Jones AD; Greene SJ; Fudim M; Coles A; Butler J; Sharma A; Hernandez AF; Mentz RJ
J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):223-225. PubMed ID: 30540649
[TBL] [Abstract][Full Text] [Related]
13. Assessing iron status: beyond serum ferritin and transferrin saturation.
Wish JB
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S4-8. PubMed ID: 17699374
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of transferrin saturation in heart failure patients.
Campodonico J; Nicoli F; Motta I; Migone De Amicis M; Bonomi A; Cappellini M; Agostoni P
Eur J Prev Cardiol; 2021 Dec; 28(15):1639-1646. PubMed ID: 33619543
[TBL] [Abstract][Full Text] [Related]
15. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study.
González-Costello J; Comín-Colet J; Lupón J; Enjuanes C; de Antonio M; Fuentes L; Moliner-Borja P; Farré N; Zamora E; Manito N; Pujol R; Bayés-Genis A
BMC Cardiovasc Disord; 2018 Nov; 18(1):206. PubMed ID: 30382817
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure.
Lanser L; Poelzl G; Messner M; Ungericht M; Zaruba MM; Hirsch J; Hechenberger S; Obersteiner S; Koller B; Ulmer H; Weiss G
J Am Heart Assoc; 2024 May; 13(9):e032540. PubMed ID: 38639356
[TBL] [Abstract][Full Text] [Related]
17. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients.
Grote Beverborg N; Klip IT; Meijers WC; Voors AA; Vegter EL; van der Wal HH; Swinkels DW; van Pelt J; Mulder AB; Bulstra SK; Vellenga E; Mariani MA; de Boer RA; van Veldhuisen DJ; van der Meer P
Circ Heart Fail; 2018 Feb; 11(2):e004519. PubMed ID: 29382661
[TBL] [Abstract][Full Text] [Related]
18. The transferrin/log(ferritin) ratio: a new tool for the diagnosis of iron deficiency anemia.
Castel R; Tax MG; Droogendijk J; Leers MP; Beukers R; Levin MD; Sonneveld P; Berendes PB
Clin Chem Lab Med; 2012 Feb; 50(8):1343-9. PubMed ID: 22868798
[TBL] [Abstract][Full Text] [Related]
19. Parenteral versus oral iron therapy for adults and children with chronic kidney disease.
Albaramki J; Hodson EM; Craig JC; Webster AC
Cochrane Database Syst Rev; 2012 Jan; 1():CD007857. PubMed ID: 22258974
[TBL] [Abstract][Full Text] [Related]
20. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality.
Sierpinski R; Josiak K; Suchocki T; Wojtas-Polc K; Mazur G; Butrym A; Rozentryt P; van der Meer P; Comin-Colet J; von Haehling S; Kosmala W; Przewlocka-Kosmala M; Banasiak W; Nowak J; Voors AA; Anker SD; Cleland JGF; Ponikowski P; Jankowska EA
Eur J Heart Fail; 2021 Jun; 23(6):919-932. PubMed ID: 33111457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
